OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
121 hedge funds and large institutions have $163M invested in Orexigen Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
46% less call options, than puts
Call options by funds: $961K | Put options by funds: $1.77M
Holders
121
Holding in Top 10
3
Calls
$961K
Puts
$1.77M
Top Buyers
| 1 | +$3.44M | |
| 2 | +$2.51M | |
| 3 | +$2.49M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.29M |
| 5 |
SIM
Spark Investment Management
New York
|
+$655K |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$2.44M | |
| 3 | -$2.29M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.09M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.98M |